Insulin Dosing for Hospitalized Patient with Gangrene and Uncontrolled Diabetes
Immediate Insulin Initiation: Basal-Bolus Regimen Required
For this 82kg patient with A1c 10.1%, 15-year diabetes duration, and acute foot gangrene requiring hospitalization, initiate basal-bolus insulin therapy immediately with Lantus 25-33 units once daily (0.3-0.4 units/kg/day as total daily dose, split 50% basal/50% prandial), insulin-to-carbohydrate ratio (ICR) of 1:10, and insulin sensitivity factor (ISF) of 30-40 mg/dL per unit. 1, 2, 3
Lantus (Basal Insulin) Dose Calculation
Initial Dose: 25-33 Units Once Daily
- Start with 0.3-0.4 units/kg/day as total daily insulin dose given the severe hyperglycemia (A1c 10.1%) and acute illness with gangrene 2, 3
- For this 82kg patient: 0.3 × 82 = 24.6 units, or 0.4 × 82 = 32.8 units total daily dose 2
- Give 50% as basal insulin (Lantus): 12-16 units once daily 1, 2
- However, for hospitalized patients with severe hyperglycemia and acute illness, use the higher end: Start with 25-33 units Lantus once daily (approximately 0.3-0.4 units/kg/day) 2, 3
Critical Adjustments for Renal Impairment
- With GFR 71 ml/min (Stage 2 CKD), initiate conservatively at the lower end of dosing range to avoid hypoglycemia 1
- Reduce dose by 10-20% if hypoglycemia occurs 1, 2
- Start with 25 units Lantus once daily given renal function and acute illness 1, 2
Medication Adjustments Required
- STOP Amaryl (glimepiride) immediately - sulfonylureas significantly increase hypoglycemia risk when combined with insulin in hospitalized patients 1
- Continue Metformin 1000mg BID unless contraindicated by acute illness or declining renal function 4, 2
- Continue Jardiance 25mg - SGLT2 inhibitors provide cardiovascular and renal protection, but monitor closely for euglycemic DKA given insulin requirement and acute stress 1, 5
- Pause Jardiance temporarily if patient becomes NPO or develops signs of infection/sepsis to reduce DKA risk 1
Prandial Insulin Dosing
Initial Prandial Dose: 12-16 Units Daily (Divided)
- Give remaining 50% of total daily dose as prandial insulin divided among three meals 1, 2
- For 25-33 units total daily dose: 4-5 units rapid-acting insulin (Humalog/NovoLog/Apidra) before each meal 1, 2
- Start with 4 units before each meal and adjust based on postprandial glucose readings 4, 2
Insulin-to-Carbohydrate Ratio (ICR)
ICR = 1:10 (1 unit per 10 grams carbohydrate)
- Calculate using 500 Rule: 500 ÷ Total Daily Dose 2
- For 30 units total daily dose: 500 ÷ 30 = 16.7, round to 1:15-20 2
- However, for severe hyperglycemia (A1c 10.1%), start more aggressively with 1:10 2
- This means 1 unit of rapid-acting insulin covers 10 grams of carbohydrate 2
Practical Application
- If patient eats 60 grams carbohydrate at lunch: 60 ÷ 10 = 6 units rapid-acting insulin 2
- Adjust ICR by 1-2 units every 3 days based on 2-hour postprandial glucose readings 4, 2
Insulin Sensitivity Factor (ISF)
ISF = 30-40 mg/dL per unit
- Calculate using 1500 Rule: 1500 ÷ Total Daily Dose 2
- For 30 units total daily dose: 1500 ÷ 30 = 50 mg/dL per unit 2
- For severe hyperglycemia and acute illness, use more aggressive ISF of 30-40 to correct hyperglycemia faster 2
- This means 1 unit of rapid-acting insulin lowers blood glucose by 30-40 mg/dL 2
Correction Dose Calculation
- Target glucose: 140 mg/dL (hospitalized patient target 140-180 mg/dL) 1
- If pre-meal glucose is 240 mg/dL: (240 - 140) ÷ 40 = 2.5 units correction dose 2
- Add correction dose to carbohydrate coverage dose 2
Titration Protocol
Basal Insulin Adjustment (Every 3 Days)
- If fasting glucose ≥180 mg/dL: Increase Lantus by 4 units 2, 3
- If fasting glucose 140-179 mg/dL: Increase Lantus by 2 units 2, 3
- Target fasting glucose: 80-130 mg/dL (may accept 100-140 mg/dL in hospitalized elderly patient) 1, 2
- If fasting glucose <80 mg/dL on 2+ occasions: Decrease Lantus by 2 units 2
Prandial Insulin Adjustment (Every 3 Days)
- Adjust based on 2-hour postprandial glucose readings 4, 2
- If postprandial glucose >180 mg/dL: Increase prandial dose by 1-2 units 4, 2
- If postprandial glucose <100 mg/dL: Decrease prandial dose by 1-2 units 2
Critical Threshold Warning
- When Lantus exceeds 0.5 units/kg/day (41 units for 82kg patient), STOP escalating basal insulin 4, 2
- Instead, intensify prandial insulin coverage to avoid "overbasalization" 4, 2
- Signs of overbasalization: bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, high glucose variability 4, 2
Monitoring Requirements
Blood Glucose Testing Schedule
- Check fasting glucose daily to guide Lantus titration 1, 2
- Check pre-meal glucose before each meal (if eating) 1
- Check bedtime glucose to assess overnight basal coverage 1, 2
- Check every 6 hours minimum if NPO or poor oral intake 6
Laboratory Monitoring
- Daily creatinine and electrolytes given renal impairment and SGLT2 inhibitor use 1
- Monitor for ketones if glucose >250 mg/dL or patient develops nausea/vomiting (SGLT2i + insulin = DKA risk) 1
- Recheck A1c in 3 months after discharge 1, 2
Special Considerations for Gangrene/Acute Illness
Stress Hyperglycemia Management
- Acute illness increases insulin requirements by 30-50% 6
- If patient develops sepsis or requires surgery, expect insulin needs to DOUBLE 6
- Reduce insulin by 20-30% immediately when acute illness resolves to prevent hypoglycemia 6
NPO/Poor Oral Intake Protocol
- If NPO: Give 100% of Lantus dose, HOLD all prandial insulin 1, 6
- Use correction doses only if patient actually eats 6
- Basal insulin represents 30-50% of total daily requirements and prevents ketosis 1, 6
Renal Function Deterioration
- If GFR drops below 45 ml/min: Reduce Metformin to 1000mg daily maximum 1
- If GFR drops below 30 ml/min: STOP Metformin 1
- Reduce insulin doses by 10-20% with declining renal function to prevent prolonged hypoglycemia 1
Common Pitfalls to Avoid
Critical Errors in Hospitalized Patients
- DO NOT continue sliding-scale insulin monotherapy - this reactive approach leads to poor control and glucose variability 1
- DO NOT delay insulin intensification - this patient needs basal-bolus therapy NOW, not gradual titration 1, 2
- DO NOT continue Amaryl with insulin - sulfonylureas cause severe hypoglycemia in hospitalized patients 1
- DO NOT escalate Lantus beyond 0.5 units/kg/day without adding prandial insulin - this causes overbasalization 4, 2
SGLT2 Inhibitor Safety
- PAUSE Jardiance if patient becomes NPO, develops infection, or requires surgery 1
- Monitor for euglycemic DKA (ketones with glucose <250 mg/dL) - this is a medical emergency 1
- Maintain at least low-dose insulin when using SGLT2i to prevent DKA 1
Hypoglycemia Prevention
- Reduce insulin by 10-20% immediately if ANY hypoglycemia occurs 1, 2
- Elderly patients (this patient is likely >60 years given 15-year diabetes duration) require more conservative targets 1
- Accept fasting glucose 100-140 mg/dL in high-risk patients rather than aggressive 80-130 mg/dL target 1
Discharge Planning
Transition to Outpatient Regimen
- Continue basal-bolus regimen at discharge - do NOT simplify to basal-only with A1c 10.1% 1, 2
- Provide self-titration algorithm for patient to adjust insulin at home 2, 3
- Schedule follow-up within 2-4 weeks to reassess regimen 4
- Restart or continue Jardiance for cardiovascular/renal protection once acute illness resolves 1, 5
- Continue Metformin unless contraindicated 4, 2